scholarly journals Phase II Study of the Multitargeted Tyrosine Kinase Inhibitor XL647 in Patients with Non–Small-Cell Lung Cancer

2012 ◽  
Vol 7 (5) ◽  
pp. 856-865 ◽  
Author(s):  
M. Catherine Pietanza ◽  
Shirish M. Gadgeel ◽  
Afshin Dowlati ◽  
Thomas J. Lynch ◽  
Ravi Salgia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Phase Ii ◽  
Kinase Inhibitor ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multitargeted Tyrosine Kinase Inhibitor

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer

2019 ◽  
pp. 089719001984059
Author(s):  
Emily Miao ◽  
Nagashree Seetharamu ◽  
Kevin Sullivan ◽  
Stephen Eng ◽  
Chung-Shien Lee
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Starting Dose

Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment

2019 ◽  
Vol 133 ◽  
pp. 145-159 ◽  
Author(s):  
Nishant S. Kulkarni ◽  
Vineela Parvathaneni ◽  
Snehal K. Shukla ◽  
Leonard Barasa ◽  
Jeanette C. Perron ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Quantum Dots ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document